CHINA NATIONAL MEDICINES CORPORATION LTD.

Other languages China National Medicines Corporation Ltd.

Equities

600511

CNE000001D56

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 29/04/2024 am IST			5-day change	1st Jan Change
34.66 ^CNY	-0.80%		-1.28%	+21.10%

25/04	China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
21/03	China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
China Stocks Muted at Close as Recovery Optimism Fades; Sinopharm Jumps 6% on Upbeat 2023 Earnings	21/03
Sinopharm's 2023 Profit Climbs 9%; Shares Up 6%	21/03
China National Medicines Corporation Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
China National Medicines Deputy Manager Under Probe for Alleged Insider Trading	10/01
CASI Pharmaceuticals, Inc. Enters into an Exclusive Distribution Agreement with China National Medicines Corporation Ltd	09/12
China National Medicines' Profit Drops 16.1% in Q3	25/23/25
China National Medicines Corporation Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/23/24
Sinopharm CFO Retires; Successor Named	16/23/16
China National Medicines' Profit Climbs 14.2% in H1	24/23/24
China National Medicines Corporation Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23/23/23
China National Medicines' Q1 Profit Rises 10.9%	26/23/26
China National Medicines Corporation Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25
Sinopharm’s Profit Rises 12% in 2022; Revenue Slips 2%	23/23/23
China National Medicines' 2022 Profit Up 12%	23/23/23
Sinopharm Eyes Production of Merck's COVID-19 Drug in China	13/23/13
Sinopharm Clarifies It Is Not A Distributor for Pfizer's COVID-19 Drug	20/22/20
Sinopharm to Buy $168 Million Shares in Shyndec Pharma	30/22/30
Sinopharm Unit Wins Nod to Launch Clinical Trial of COVID-19 Nasal Drug	30/22/30
China National Medicines' Q3 Profit Rises 6%	24/22/24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages China National Medicines Corporation Ltd.

Equities

600511

CNE000001D56

Other languages

Filters